financetom
Technology
financetom
/
Technology
/
Expert Outlook: Teradyne Through The Eyes Of 9 Analysts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Expert Outlook: Teradyne Through The Eyes Of 9 Analysts
May 20, 2024 11:26 AM

Teradyne ( TER ) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 1 3 5 0 0
Last 30D 1 0 0 0 0
1M Ago 0 2 2 0 0
2M Ago 0 1 1 0 0
3M Ago 0 0 2 0 0

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $122.11, a high estimate of $161.00, and a low estimate of $110.00. This current average reflects an increase of 9.03% from the previous average price target of $112.00.

Understanding Analyst Ratings: A Comprehensive Breakdown

The standing of Teradyne ( TER ) among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Toshiya Hari Goldman Sachs Raises Buy $161.00 $118.00
Toshiya Hari Goldman Sachs Raises Neutral $118.00 $107.00
Mehdi Hosseini Susquehanna Raises Positive $130.00 $125.00
Richard Eastman Baird Raises Outperform $120.00 $110.00
C J Muse Cantor Fitzgerald Maintains Neutral $110.00 -
Mark Lipacis Evercore ISI Group Announces Outperform $130.00 -
Samik Chatterjee JP Morgan Raises Neutral $110.00 $100.00
C J Muse Cantor Fitzgerald Maintains Neutral $110.00 -
C J Muse Cantor Fitzgerald Maintains Neutral $110.00 -

Key Insights:

Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Teradyne ( TER ). This information provides a snapshot of how analysts perceive the current state of the company.

Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Teradyne ( TER ) compared to the broader market.

Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Teradyne's ( TER ) stock. This comparison reveals trends in analysts' expectations over time.

Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Teradyne's ( TER ) market standing. Stay informed and make data-driven decisions with our Ratings Table.

Stay up to date on Teradyne ( TER ) analyst ratings.

Unveiling the Story Behind Teradyne

Teradyne ( TER ) provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne ( TER ) serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing. Teradyne ( TER ) serves vertically integrated, fabless, and foundry chipmakers with its equipment.

Teradyne: Financial Performance Dissected

Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.

Revenue Challenges: Teradyne's ( TER ) revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -2.87%. This indicates a decrease in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 10.7%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): Teradyne's ( TER ) ROE stands out, surpassing industry averages. With an impressive ROE of 2.53%, the company demonstrates effective use of equity capital and strong financial performance.

Return on Assets (ROA): Teradyne's ( TER ) ROA stands out, surpassing industry averages. With an impressive ROA of 1.86%, the company demonstrates effective utilization of assets and strong financial performance.

Debt Management: Teradyne's ( TER ) debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.03.

The Core of Analyst Ratings: What Every Investor Should Know

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Richest YouTube Star MrBeast’s Firm Files Trademark With Crypto Ambitions
Richest YouTube Star MrBeast’s Firm Files Trademark With Crypto Ambitions
Oct 18, 2025
Beast Holdings, the business entity tied to YouTube ( GOOG ) personality Jimmy ‘MrBeast’ Donaldson, has filed a U.S. trademark application for “MrBeast Financial,” with language suggesting a possible push into crypto. The application includes services like cryptocurrency payment processing, crypto exchange, and trading through decentralized exchanges (DEXs). The filing also mentions downloadable software and software-as-a-service (SaaS) tools for managing...
How Avast Helps Protect Millions From Online Scams, Malware, and Phishing in 2025 - Report by Expert Consumers
How Avast Helps Protect Millions From Online Scams, Malware, and Phishing in 2025 - Report by Expert Consumers
Oct 18, 2025
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Expert Consumers has recognized Avast, a global leader in digital security and privacy, for its advanced protection against online scams, phishing attacks, and malware. The recognition highlights Avast's continuous innovation in cybersecurity and its AI-powered approach to defending users worldwide from increasingly sophisticated threats. Avast  is known for providing comprehensive digital protection across...
Wialon Announces Top 10 GPS Hardware Manufacturers for 2025
Wialon Announces Top 10 GPS Hardware Manufacturers for 2025
Oct 18, 2025
DUBAI, UAE, Oct. 19, 2025 /PRNewswire/ -- Teltonika Telematics has once again been recognized as the global leader in hardware for fleet management and digitalization, taking the #1 position in the Wialon GPS Hardware Manufacturers Top 10: 2025 edition. The award was announced at the annual Wialon Community Reunion in Dubai, gathering top industry players ahead of GITEX Global. This marks...
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer
Oct 18, 2025
BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients with BRAF V600E-mutant metastatic non-small cell lung cancer after approximately four years Results from the Phase 2 PHAROS trial potentially establish new benchmark with targeted combination therapies for this patient population NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. ( PFE ) today announced updated...
Copyright 2023-2026 - www.financetom.com All Rights Reserved